SCHEMBL6950824

SCHEMBL6950824

Cc1nc(N2CCc3ccccc3CC2)c(C#N)c(=O)n1NC(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.41
AKT1 P31749 5/20 0.40
AKT2 P31751 5/20 0.40
AKT3 Q9Y243 5/20 0.40
ALDH1A1 P00352 8/20 0.38
KDM4E B2RXH2 8/20 0.38
HPGD P15428 7/20 0.38
HTT P42858 5/20 0.38
MAPT P10636 4/20 0.38
NPSR1 Q6W5P4 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HSD17B10 Q99714 3/20 0.38
HIF1A Q16665 2/20 0.38
PLK1 P53350 1/20 0.38
RCE1 Q9Y256 1/20 0.38
TP53 P04637 1/20 0.38
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947580 0.87 HPGD (0.40) GRM2AKT1AKT2AKT3ALDH1A1
SCHEMBL6955743 0.84 GRM2 (0.39) GRM2AKT1AKT2AKT3ALDH1A1
SCHEMBL6953008 0.82 GRM2 (0.38) GRM2AKT1AKT2AKT3ALDH1A1
SCHEMBL6949302 0.81 GRM2 (0.43) GRM2ALDH1A1KDM4EHPGDHTT
SCHEMBL6951651 0.80 HPGD (0.43) GRM2ALDH1A1KDM4EHPGDHTT
SCHEMBL6947212 0.80 HPGD (0.41) GRM2AKT1AKT2AKT3ALDH1A1
SCHEMBL6949165 0.80 GRM2 (0.44) GRM2AKT1AKT2AKT3ALDH1A1
SCHEMBL6949798 0.80 GRM2 (0.41) GRM2AKT1AKT2AKT3ALDH1A1
SCHEMBL6952709 0.79 GRM2 (0.42) GRM2ALDH1A1KDM4EHPGDHTT
SCHEMBL6953535 0.79 LIPE (0.38) GRM2AKT1AKT2AKT3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed